Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine and Intermittent Hypoxia for Leg Function in SCI
NCT02323698Phase 2Completed
- Sponsor
- Spaulding Rehabilitation Hospital
- Start
- Jan 2019
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of caffeine in spinal cord injury (SCI), sponsored by Spaulding Rehabilitation Hospital. Started Jan 2019; status: completed.
02
Drugs
caffeine
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT02323698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02323698.